Molecular Diagnostic Services
Syndrome Evaluation System (SES)- A patented technology that comprises of rapid multiplex amplification and accurate identification of the virulence associated genes of the causative agents or organisms. This amazingly fast and accurate platform transcends all conventional diagnostic tests and helpful when organisms are difficult to cultivate or difficult to find. The accurate and rapid identification of the causative agents (6-8 hours of process time) empowers the clinician to initiate targeted therapy and thus save lives and significantly reduce disabilities such as blindness, paralysis, compromised mental faculties.
The technologies currently available for diagnosis of infections are grossly inadequate to detect and institute specific therapy in critical illnesses resulting in loss of function or loss of life.
The technology
The technology involves isolation of the genetic material of the causative agent from the given specimen and simultaneously amplifies the "Syndrome Specific Signature genes" of all the causative agents, followed by "Syndrome Specific Hybridization".
The amplification of the gene allows for higher sensitivity of the test and the re-naturation of the amplified signature gene to its chemically identified complementary gene sequence on the SES allows for higher specificity of the test. And the simultaneous amplification of all the causative agents allows for early diagnosis of the infection and initiation of therapy.
XCyton offers Molecular Diagnostic Service and also helps in the management of critical infections through its Syndrome Evaluation System.
XCyto Screen
XCyto Screen (for Syndrome based Diagnostics) is a service provided by XCyton for simultaneous detection of all the causative agents in a single sample.
Turnaround time - 24 hours from the receipt of sample
For further details, contact: 093412 64132